Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $8.95.

  • Ironwood Pharmaceuticals' Times Interest Earned rose 22883.33% to $8.95 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.65, marking a year-over-year increase of 1962.87%. This contributed to the annual value of $2.82 for FY2024, which is 10644.92% up from last year.
  • Ironwood Pharmaceuticals' Times Interest Earned amounted to $8.95 in Q3 2025, which was up 22883.33% from $5.42 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Times Interest Earned high stood at $44.93 for Q3 2022, and its period low was -$588.66 during Q2 2023.
  • For the 5-year period, Ironwood Pharmaceuticals' Times Interest Earned averaged around -$18.39, with its median value being $5.95 (2021).
  • Its Times Interest Earned has fluctuated over the past 5 years, first skyrocketed by 52940.95% in 2022, then crashed by 243434.22% in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Times Interest Earned (Quarter) stood at $7.12 in 2021, then surged by 529.41% to $44.8 in 2022, then crashed by 90.04% to $4.46 in 2023, then decreased by 20.84% to $3.53 in 2024, then skyrocketed by 153.34% to $8.95 in 2025.
  • Its last three reported values are $8.95 in Q3 2025, $5.42 for Q2 2025, and -$3.61 during Q1 2025.